- We downgrade our rating for DHC from BUY to OUTPERFORM and trim our target price by 4%. While DHC’s business experienced a recovery in Q1 2023, the demand outlook has worsened. - We cut our 2023/24/25F NPAT by 12%/15%/9% due to lower assumptions for pri